Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Even the solid proposals set out by the Trump administration are being undermined by its actions taken elsewhere.

Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide weight-control medications to its members.

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Related FDA warns of fake Ozempic Type 2 diabetes injection drugs ... Trump wants to equalize Medicare payments for drugs, including the treatment of cancer, regardless of where the patients ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...